Nerve Enlargement in Patients with INF2 Variants Causing Peripheral Neuropathy and Focal Segmental Glomerulosclerosis

<b>Background</b>: Charcot–Marie–Tooth (CMT) disease is an inherited peripheral neuropathy primarily involving motor and sensory neurons. Mutations in INF2, an actin assembly factor, cause two diseases: peripheral neuropathy CMT-DIE (MIM614455) and/or focal segmental glomerulosclerosis (...

Full description

Saved in:
Bibliographic Details
Main Authors: Quynh Tran Thuy Huong, Linh Tran Nguyen Truc, Hiroko Ueda, Kenji Fukui, Koichiro Higasa, Yoshinori Sato, Shinichi Takeda, Motoshi Hattori, Hiroyasu Tsukaguchi
Format: Article
Language:English
Published: MDPI AG 2025-01-01
Series:Biomedicines
Subjects:
Online Access:https://www.mdpi.com/2227-9059/13/1/127
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832588955775664128
author Quynh Tran Thuy Huong
Linh Tran Nguyen Truc
Hiroko Ueda
Kenji Fukui
Koichiro Higasa
Yoshinori Sato
Shinichi Takeda
Motoshi Hattori
Hiroyasu Tsukaguchi
author_facet Quynh Tran Thuy Huong
Linh Tran Nguyen Truc
Hiroko Ueda
Kenji Fukui
Koichiro Higasa
Yoshinori Sato
Shinichi Takeda
Motoshi Hattori
Hiroyasu Tsukaguchi
author_sort Quynh Tran Thuy Huong
collection DOAJ
description <b>Background</b>: Charcot–Marie–Tooth (CMT) disease is an inherited peripheral neuropathy primarily involving motor and sensory neurons. Mutations in INF2, an actin assembly factor, cause two diseases: peripheral neuropathy CMT-DIE (MIM614455) and/or focal segmental glomerulosclerosis (FSGS). These two phenotypes arise from the progressive degeneration affecting podocytes and Schwann cells. In general, nerve enlargement has been reported in 25% of the demyelinating CMT subtype (CMT1), while little is known about the CMT-DIE caused by INF2 variants. <b>Methods</b>: To characterize the peripheral nerve phenotype of INF2-related CMT, we studied the clinical course, imaging, histology, and germline genetic variants in two unrelated CMT-DIE patients. <b>Results</b>: Patient 1 (INF2 p.Gly73Asp) and patient 2 (p.Val108Asp) first noticed walking difficulties at 10 to 12 years old. Both of them were electrophysiologically diagnosed with demyelinating neuropathy. In patient 2, the sural nerve biopsy revealed an onion bulb formation. Both patients developed nephrotic syndrome almost simultaneously with CMT and progressed into renal failure at the age of 16 to 17 years. Around the age of 30 years, both patients manifested multiple hypertrophy of the trunk, plexus, and root in the cervical, brachial, lumbosacral nerves, and cauda equina. The histology of the cervical mass in patient 2 revealed Schwannoma. Exome analysis showed that patient 2 harbors a germline <i>LZTR1</i> p.Arg68Gly variant, while patient 1 has no schwannomatosis-related mutations. <b>Conclusions</b>: Peripheral neuropathy caused by INF2 variants may lead to the development of multifocal hypertrophy with age, likely due to the initial demyelination and subsequent Schwann cell proliferation. Schwannoma could co-occur when the tissues attain additional hits in schwannomatosis-related genes (e.g., <i>LZTR1</i>).
format Article
id doaj-art-2075cccb738d4c638290b161c8d140d5
institution Kabale University
issn 2227-9059
language English
publishDate 2025-01-01
publisher MDPI AG
record_format Article
series Biomedicines
spelling doaj-art-2075cccb738d4c638290b161c8d140d52025-01-24T13:24:06ZengMDPI AGBiomedicines2227-90592025-01-0113112710.3390/biomedicines13010127Nerve Enlargement in Patients with INF2 Variants Causing Peripheral Neuropathy and Focal Segmental GlomerulosclerosisQuynh Tran Thuy Huong0Linh Tran Nguyen Truc1Hiroko Ueda2Kenji Fukui3Koichiro Higasa4Yoshinori Sato5Shinichi Takeda6Motoshi Hattori7Hiroyasu Tsukaguchi8Second Department of Internal Medicine, Division of Nephrology, Kansai Medical University, Hirakata 573-1010, JapanSecond Department of Internal Medicine, Division of Nephrology, Kansai Medical University, Hirakata 573-1010, JapanSecond Department of Internal Medicine, Division of Nephrology, Kansai Medical University, Hirakata 573-1010, JapanDepartment of Biochemistry, Faculty of Medicine, Osaka Medical and Pharmaceutical University, Takatsuki 569-8686, JapanDepartment of Genome Analysis, Institute of Biomedical Science, Kansai Medical University, Hirakata 573-1010, JapanDepartment of Medicine, Division of Nephrology, Showa University School of Medicine, Fujigaoka Hospital, Yokohama 227-8501, JapanInternal Medicine, Kurobe City Hospital, Toyama 938-8502, JapanDepartment of Pediatric Nephrology, Tokyo Women’s Medical University, Tokyo 162-8666, JapanSecond Department of Internal Medicine, Division of Nephrology, Kansai Medical University, Hirakata 573-1010, Japan<b>Background</b>: Charcot–Marie–Tooth (CMT) disease is an inherited peripheral neuropathy primarily involving motor and sensory neurons. Mutations in INF2, an actin assembly factor, cause two diseases: peripheral neuropathy CMT-DIE (MIM614455) and/or focal segmental glomerulosclerosis (FSGS). These two phenotypes arise from the progressive degeneration affecting podocytes and Schwann cells. In general, nerve enlargement has been reported in 25% of the demyelinating CMT subtype (CMT1), while little is known about the CMT-DIE caused by INF2 variants. <b>Methods</b>: To characterize the peripheral nerve phenotype of INF2-related CMT, we studied the clinical course, imaging, histology, and germline genetic variants in two unrelated CMT-DIE patients. <b>Results</b>: Patient 1 (INF2 p.Gly73Asp) and patient 2 (p.Val108Asp) first noticed walking difficulties at 10 to 12 years old. Both of them were electrophysiologically diagnosed with demyelinating neuropathy. In patient 2, the sural nerve biopsy revealed an onion bulb formation. Both patients developed nephrotic syndrome almost simultaneously with CMT and progressed into renal failure at the age of 16 to 17 years. Around the age of 30 years, both patients manifested multiple hypertrophy of the trunk, plexus, and root in the cervical, brachial, lumbosacral nerves, and cauda equina. The histology of the cervical mass in patient 2 revealed Schwannoma. Exome analysis showed that patient 2 harbors a germline <i>LZTR1</i> p.Arg68Gly variant, while patient 1 has no schwannomatosis-related mutations. <b>Conclusions</b>: Peripheral neuropathy caused by INF2 variants may lead to the development of multifocal hypertrophy with age, likely due to the initial demyelination and subsequent Schwann cell proliferation. Schwannoma could co-occur when the tissues attain additional hits in schwannomatosis-related genes (e.g., <i>LZTR1</i>).https://www.mdpi.com/2227-9059/13/1/127FSGSCharcot–Marie–Toothschwannomatosisforminactin cytoskeleton
spellingShingle Quynh Tran Thuy Huong
Linh Tran Nguyen Truc
Hiroko Ueda
Kenji Fukui
Koichiro Higasa
Yoshinori Sato
Shinichi Takeda
Motoshi Hattori
Hiroyasu Tsukaguchi
Nerve Enlargement in Patients with INF2 Variants Causing Peripheral Neuropathy and Focal Segmental Glomerulosclerosis
Biomedicines
FSGS
Charcot–Marie–Tooth
schwannomatosis
formin
actin cytoskeleton
title Nerve Enlargement in Patients with INF2 Variants Causing Peripheral Neuropathy and Focal Segmental Glomerulosclerosis
title_full Nerve Enlargement in Patients with INF2 Variants Causing Peripheral Neuropathy and Focal Segmental Glomerulosclerosis
title_fullStr Nerve Enlargement in Patients with INF2 Variants Causing Peripheral Neuropathy and Focal Segmental Glomerulosclerosis
title_full_unstemmed Nerve Enlargement in Patients with INF2 Variants Causing Peripheral Neuropathy and Focal Segmental Glomerulosclerosis
title_short Nerve Enlargement in Patients with INF2 Variants Causing Peripheral Neuropathy and Focal Segmental Glomerulosclerosis
title_sort nerve enlargement in patients with inf2 variants causing peripheral neuropathy and focal segmental glomerulosclerosis
topic FSGS
Charcot–Marie–Tooth
schwannomatosis
formin
actin cytoskeleton
url https://www.mdpi.com/2227-9059/13/1/127
work_keys_str_mv AT quynhtranthuyhuong nerveenlargementinpatientswithinf2variantscausingperipheralneuropathyandfocalsegmentalglomerulosclerosis
AT linhtrannguyentruc nerveenlargementinpatientswithinf2variantscausingperipheralneuropathyandfocalsegmentalglomerulosclerosis
AT hirokoueda nerveenlargementinpatientswithinf2variantscausingperipheralneuropathyandfocalsegmentalglomerulosclerosis
AT kenjifukui nerveenlargementinpatientswithinf2variantscausingperipheralneuropathyandfocalsegmentalglomerulosclerosis
AT koichirohigasa nerveenlargementinpatientswithinf2variantscausingperipheralneuropathyandfocalsegmentalglomerulosclerosis
AT yoshinorisato nerveenlargementinpatientswithinf2variantscausingperipheralneuropathyandfocalsegmentalglomerulosclerosis
AT shinichitakeda nerveenlargementinpatientswithinf2variantscausingperipheralneuropathyandfocalsegmentalglomerulosclerosis
AT motoshihattori nerveenlargementinpatientswithinf2variantscausingperipheralneuropathyandfocalsegmentalglomerulosclerosis
AT hiroyasutsukaguchi nerveenlargementinpatientswithinf2variantscausingperipheralneuropathyandfocalsegmentalglomerulosclerosis